- Associated Press - Wednesday, May 13, 2015

ERIE, Pa. (AP) - The lead researcher for a noninvasive cancer treatment filed protocols to begin human trials in Italy.

If approved, humans could begin receiving treatment from the Kanzius Noninvasive Radiowave Cancer Device as soon as next spring, the Erie Times-News reports (https://bit.ly/1E5zMMJ).

The lead researcher for the Kanzius project, Steven Curley, said his team has received “great results” with lab animals, which he hopes will carry over to people.

“Until we treat people, we don’t know how effective this treatment will be,” Curley said.

With this device, microscopic pieces of metal target cancer cells and radio waves heat and destroy them. It also works without metal particles in combination with low doses of traditional chemotherapy.

The trials will take place in Naples, Italy, which has a shorter regulatory process than the United States. The first round, which will test the device’s safety, will take six to nine months. Curley said if everything goes well, the tests may be replicated at Baylor College of Medicine in Houston. Phase 2 trials are planned for Erie, Houston, Fort Myers and various other locations, he added.

Device inventor John Kanzius, of Erie, came up with the theory of treating cancer noninvasively in 2004, two years after his own diagnosis. His device uses radio waves to heat and destroy cancer cells without harming healthy cells. He died of leukemia in 2009.

Kanzius had no medical background but built the device after researching cancer and learning about radio waves. He was formerly a partner at Erie’s Jet Broadcasting Co.


Information from: Erie Times-News, https://www.goerie.com

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide